Puberty blockers, drugs that suppress puberty hormones, have been controversial in gender-affirming care due to questions about their efficacy and long-term effects.
Scotland’s decision follows NHS England’s confirmation to stop prescribing puberty blockers in March, reflecting growing concerns about the well-being and safety of young people receiving gender-affirming care.
The Sandyford clinic in Glasgow is the sole specialist service for under-18s in Scotland, but it faces high demand, with 1,100 patients on the waiting list by the end of 2023.
Presently, 43 patients will continue to receive puberty blockers or “gender-affirming hormones,” but prescriptions will be deferred until they reach 18, reflecting evolving understanding and the need for evidence-based practices.
A statement from Vic Valentine, of Scottish Trans and the Equality Network said:
“This decision has been taken within the context where the reality of trans people’s experiences and lives is questioned almost daily in some of the media and some political circles.”
“This makes us worry that the decision has been influenced by that context rather than solely through consideration of the best interests of trans children and young people.”
Valentine also says the decision will “harm trans children and young people”.
The ongoing debate underscores the need for a nuanced, evidence-based approach that prioritises patients’ best interests and acknowledges the complexities of gender identity and expression.
Collaboration among the Scottish government, healthcare providers, and academic partners is essential to establish evidence-based methods and guidelines for safe and effective gender-affirming care.
Transparency, compassion, and a commitment to patients’ well-being should guide future policies and practices in this critical healthcare area.
The Scottish and UK governments have yet to release official statements on the decision.
Featured Image credit: Pexels Free Photos.
I am a third-year Politics and Journalism Studies student at the University of Stirling (2022-) and a writer and sub-editor for the Brig for over a year (Nov. 2023-), focusing mainly on political topics.
